News

Universe Pharmaceuticals to Undertake Significant Share Consolidation

Universe Pharmaceuticals to Undertake Significant Share Consolidation

Significant Share Consolidation Announced by Universe Pharmaceuticals

Universe Pharmaceuticals INC (NASDAQ: UPC) has made headlines with its recent announcement regarding a share consolidation. This strategic decision will see the company consolidate every 40 ordinary shares, which have a par value of US$0.28125 each, into a single ordinary share valued at US$11.25. This transformation of share capital is poised to simplify the company's equity structure and enhance shareholder value.

Effective Date for the Share Consolidation

The effective date for this consolidation is set for March 24, 2025. Starting at the opening of trading on this date, the company’s shares will begin trading on a post-consolidation basis on the Nasdaq Capital Market. While the trading symbol will remain "UPC," the shares will adopt a new CUSIP number: G9442G 138. Importantly, no fractional shares will be issued as a result of this consolidation; instead, they will be rounded up to the nearest whole number.

About Universe Pharmaceuticals INC

Headquartered in Ji’an, China, Universe Pharmaceuticals INC focuses on the production and distribution of pharmaceutical products. The company's niche is in traditional Chinese medicine derivatives, primarily targeting the elderly population in order to improve their health and enhance overall well-being. Beyond this core offering, Universe Pharmaceuticals also engages in the distribution of biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements sourced from various third-party pharmaceutical manufacturers. Presently, their products enjoy a market presence across 30 provinces in China.

Company's Vision and Future Directions

The vision of Universe Pharmaceuticals is to address the unique health challenges faced by aging populations, offering effective solutions through their sophisticated manufacturing processes and extensive distribution network. As the demand for traditional medicine rises, the company's strategic positioning in this sector could position it well for future growth. By consolidating shares, Universe Pharmaceuticals is not merely adjusting its share structure; it is also signaling a commitment to improve shareholder equity and encourage greater investments.

Contact Information

For further inquiries or more information about Universe Pharmaceuticals, interested parties can reach out to Ms. Lin Yang, the Chief Financial Officer. She can be contacted via email at lin.yang@universe-pharmacy.com.

Frequently Asked Questions

What is the reason for the share consolidation by Universe Pharmaceuticals?

The share consolidation aims to simplify the company's equity structure and potentially increase the perceived value of the shares for investors.

When will the share consolidation take effect?

The share consolidation will take effect on March 24, 2025, marking the start of trading on a post-consolidation basis.

How will fractional shares be handled post-consolidation?

In the event of fractional shares from the consolidation process, these will be rounded up to the nearest whole share, ensuring that all shareholders receive complete shares.

What products does Universe Pharmaceuticals distribute?

Universe Pharmaceuticals specializes in traditional Chinese medicine derivatives, biomedical drugs, medical instruments, and dietary supplements.

How can interested parties learn more about the company?

For more information about Universe Pharmaceuticals INC, interested individuals can visit the company’s official website or reach out directly through the provided contact details.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Curaleaf Secures Key Approvals in Aurora Acquisition Bid

Updated Category News Views 100

Curaleaf Gets a Green Light for Acquisition Talk about maneuvering a minefield, eh? Curaleaf Holdings just stamped out the last of its paperwork in the cutthroat cannabis industry to acquire Aurora Cannabis. We're looking at the final sign-offs from not one, but two major players: Germany and Canada's competition authorities. That's no small feat when you're trying to...

Continue Reading
NHTSA, Ad Council Unveil New Anti-Buzzed Driving PSAs

Updated Category News Views 51

Taking Aim at a Deadly Habit Everyone's got that gut feeling when a day-long meeting runs over or you're stuck in traffic — impatience morphed with slow burn menace. Now picture a whole campaign gunning for that vibe but in the hands of the young folks, those from 21 to 34. That's what we're talking about here, with the Ad Council and NHTSA serving up some fresh public...

Continue Reading
CURE Intl and Thoughtworks Step Into Digital Era

Updated Category News Views 126

Pushing Paper Out, Digitizing In In a world where tech is king, why were hospitals—crucial, life-saving institutions—still bogged down by dusty folders and ink smudges? Well, not anymore for CURE International, not with Thoughtworks stepping up to the plate. This ain't just swapping paper for pixels; it's a lifeline for kids getting world-class surgical care without...

Continue Reading
Ampa One Partners with Wave Neuroscience for PTSD

Updated Category News Views 51

Ampa and Wave Neuroscience Join Forces In a fresh twist on the neurotechnology scene, Ampa's portable TMS system is teaming up with Wave Neuroscience's MeRT to target PTSD. Science and partnership—combined like a decent scotch and a well-done steak, if you ask me. They've got the FDA clearance on their side, and they're bringing it to the clinics without demanding those...

Continue Reading
High Stakes at Bragg Companies' Crane Auction

Updated Category News Views 74

Cranes, Cash, and Competition: Auction Insights Never thought a bunch of cranes and trucks could have me so interested, but here we are staring down one of the big ones this December. Bragg Companies plans to lift the lid on its fleet with an absolute auction conducted by none other than Jeff Martin Auctioneers. If you aren't in the loop, 'absolute' means no min bid,...

Continue Reading
Kavalan Whisky Expands into Ghana with Say Cheers

Updated Category News Views 122

A Taste of Taiwan in Ghana The whisky world just got a bit smaller with Kavalan’s latest move If you know whisky, you know Kavalan, the Taiwanese gem that's been steadily building its global footprint. And now, they've set their sights on Ghana. Yup, this one's not about rattling sabers but raising glasses! Partnering with Say Cheers Limited, Kavalan enters Ghana,...

Continue Reading
Cepheid Expands Diagnostic Potential with IVDR Approval

Updated Category News Views 106

A Key Milestone for Cepheid Breathing new life into Europe's diagnostic landscape, Cepheid's Xpert Respiratory Panel just snagged the CE marking under the IVDR. This ain't just some technical checkbox; this test's got the goods to spot 13 respiratory pathogens from one measly swab. It's a hefty lineup—think Adenovirus, different flavors of flu, and even the sneaky...

Continue Reading
The DOG CATCHER: A New Spin on Pet Waste Cleanup

Updated Category News Views 26

Revolutionizing the Dreaded Pet Waste Duty Folks, here's a little dose of innovation from the streets of Baltimore: a gadget called the DOG CATCHER. No, it’s not about catching stray dogs, but dealing with their unpleasant leavings. This invention's got a patent pending and all, promising to make the nasty business of dog waste collection a whole lot less disgusting. I...

Continue Reading
Autoliv Welcomes Rosenberg: Strategy Shift or Status Quo?

Updated Category News Views 183

Big Moves in the Boardroom Autoliv's latest announcement has stirred up the automotive safety world—a development that might feel like just another board shuffle, but there's more here than meets the eye. On November 10, 2026, Autoliv decided to toss Joachim Rosenberg into the mix as an independent director, bumping its board headcount from nine to ten. Who's This...

Continue Reading
McKinley Irvin Adds Veteran Willa Staats to Legal Team

Updated Category News Views 50

New Talent Joins a Leading Family Law Firm Some folks think of family law as just another branch of the legal world, but let's be real—it's where emotions run high and stakes can catch you off guard like a sudden market downturn. So, when McKinley Irvin, one of the Pacific Northwest’s top family law outfits, brings someone new aboard, that’s worth putting under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Trading: TruTrade's Approach to Capital Access

Updated Category News Views 135

Transforming Access to Capital in Trading In the competitive landscape of trading, both professional and independent traders are realizing that success is no longer just about having the best strategies. Instead, the focus is shifting towards scalable capital infrastructure, a crucial element that can enhance one’s trading performance. Introducing QuickFund AI—a...

Continue Reading
NeurAxis Secures Historic FDA Clearance for Pain Treatment

Updated Category News Views 157

NeurAxis Revolutionizes Treatment for Functional Dyspepsia NeurAxis, Inc. (NYSE American: NRXS), a pioneer in medical technology, has achieved a momentous milestone by securing FDA clearance for its innovative percutaneous electrical nerve field stimulation (PENFS) technology. This approval is specifically aimed at treating functional abdominal pain (FAP) associated with...

Continue Reading
Obic Co Ltd Maintains Price Target Amid Downgrade Insights

Updated Category News Views 91

Understanding the Recent Downgrade of Obic Co Ltd Recently, there has been some notable movement in the evaluation of Obic Co Ltd (4684:JP) (OTC: OBIIF) shares. Jefferies, a respected financial services company, has downgraded Obic's stock from a Buy rating to Hold. This revision comes amidst shifting market dynamics that have brought a renewed focus on domestic demand...

Continue Reading
Varonis to Report Third Quarter Results and Conference Call

Updated Category News Views 89

Varonis to Report Third Quarter Results Soon Varonis Systems, Inc. (Nasdaq: VRNS), renowned for its innovative data security solutions, is preparing to announce its financial performance for the third quarter of 2024. Stakeholders and analysts alike are keenly awaiting this report, which will be released after the U.S. markets close, specifically on a Tuesday at the end...

Continue Reading
Innovative AvePoint Elements Transform MSP Service Delivery

Updated Category News Views 125

Advancements in Managed Services with AvePoint Elements AvePoint (NASDAQ: AVPT) is steering a monumental shift in the managed services landscape with the launch of its next-generation AvePoint Elements. This innovative solution promises to revamp client, cloud, and tenant management for managed service providers (MSPs) by harnessing the power of artificial intelligence,...

Continue Reading